Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

William J. Sandborn, Chinyu Su, Bruce E. Sands et al. · New England Journal of Medicine · 2017 · 1.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

ACG Clinical Guideline: Ulcerative Colitis in Adults

David T. Rubin, Ashwin N. Ananthakrishnan, Corey A. Siegel et al. · The American Journal of Gastroenterology · 2019 · 1.6K citations

Medicine, Clinical Sciences, Internal Medicine +16

Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

William J. Sandborn, Subrata Ghosh, Julián Panés et al. · New England Journal of Medicine · 2012 · 799 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

International ethical guidelines for biomedical research involving human subjects

Claire Gilbert Foster · Journal of Medical Ethics · 1994 · 681 citations · Full text

Public Health, Biomedical Sciences, Ethics +13

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Silvio Danese, Séverine Vermeire, Wen Zhou et al. · The Lancet · 2022 · 597 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +10